Skip to main content
. 2019 Nov 14;9:16827. doi: 10.1038/s41598-019-53394-w

Figure 5.

Figure 5

Plant GlcCer alters levels of EVs in serum and brain. Numbers of EVs (a) and exosomal expression of NCAM-1 (b) from serum samples of control or GlcCer-treated wild-type mice (n = 5, all males, each group). (c,d) NCAM-1, L1CAM, and Aβ42 levels in serum EVs of 13-month old APP mice, which were administrated GlcCer or vehicle (n = 5, 3 males and 2 females, each group). (e) NCAM-1, L1CAM, and Aβ were detected in sucrose gradient ultracentrifugation fractions of GlcCer- and vehicle-treated APP mouse brains. (f) Histogram of the size of EVs in fractions 3, 4 and 5 from panel (e). (g) Exosome-associated Aß fibrils in fractions 3, 4 and 5 from panel e were measured by PS-capture exosome ELISA and amyloid fibril-specific antibody (n = 5, 3 males and 2 females, each group). Data are the means ± SDs. *P < 0.05; **P < 0.01, ***P < 0.001 by t tests.